Clinical Trial

Effects of Photobiomodulation in Hemophilia Patients.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 12, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male hemophilia patients aged 9-14 years. It focuses on determining whether this therapy can reduce pain and swelling and improve joint range of motion when used alongside
Trial Details
NCT Number NCT07579585
Lead Sponsor Riphah International University
Conditions Hemarthrosis, Knee, Hemophilia
Enrollment 24 participants
Start Date 2026-04-05
Primary Completion 2026-07-05 (estimated)
Study Completion 2026-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-12